MedTech Dive July 20, 2021
Susan Kelly

Dive Brief:

  • After a sluggish first quarter, investment in medical device makers roared back in April through June to hit $8.2 billion, with early-stage startups among the biggest beneficiaries, according to a new report from CB Insights, whose research focuses on equity rounds to private healthcare companies.
  • Late-stage funding kept pace with the prior quarter: Robot manufacturer CMR Surgical’s $600 million round and portable dialysis system maker Quanta Dialysis Technologies’ $245 million Series D deal led the category.
  • Diabetes tech developers Fractyl Health and CeQur and pathology software startups CellsVision, Aiforia and PathAI also garnered fresh backing from investors.

Dive Insight:

The global healthcare sector attracted equity investment throughout the pandemic, and it is still pouring in. The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Medical Devices, Survey / Study, Technology, Trends
Boston Scientific’s $3.7B Axonics buy tops list of medtech M&A in 2024
Neuronetics wins FDA clearance for device to treat adolescents with depression
J&J in talks to buy Shockwave Medical: WSJ
Roche develops continuous glucose monitor with predictive algorithms
MedCity Pivot: A Conversation About Wearable Robots with Scott Davis

Share This Article